Dr. Mitchell Scheiman is currently Dean of Research, Director of Graduate Studies, and a Professor at Salus University. In the last 25 years, he has spent the majority of his professional time as a researcher involved in randomized clinical trials. He was the Study Chair of the Convergence Insufficiency Treatment Trial that was completed in 2008 and two other randomized clinical trials investigating the effectiveness of treatment for convergence insufficiency. Dr. Scheiman is currently Study Chair of the new CITT-ART study investigating the effect of vision therapy for convergence insufficiency on reading and attention. In recent years he has his research focus has shifted to the diagnosis and treatment of concussion-related vision disorders. His specialty areas are pediatric optometry, binocular vision, and vision therapy. He has published over 200 journal articles and has written four textbooks including, Clinical /Management of Binocular Vision, Optometric /Management of Learning-Related Vision Problems, Understanding and /Managing Vision Deficits: A Guide for Occupational Therapists, and Low Vision Rehabilitation: A Guide for Occupational Therapists. Dr. Scheiman is a Diplomate in Binocular Vision, Perception and Pediatric Optometry in the American Academy of Optometry, and a Fellow of the College of Optometrists in Vision Development (COVD).